Regenerative Medicine · Miami, FL
Exosome Therapy in Miami
Karli Health is led by Harvard-trained physician, researcher and published author David Karli, MD, MBA.
Exosomes are tiny, cell-free extracellular vesicles released by cells that carry molecular signals involved in cell-to-cell communication and tissue-repair signaling. They are not stem cells or living cells. At Karli Health, exosome therapy is physician-led, product source and dose documentation are reviewed before treatment, and patient outcomes are tracked through the Greyledge Data Cloud.
The Therapy
What Are Exosomes?
Exosomes are extracellular vesicles (EV), tiny membrane-bound particles released by cells that help carry signals from one cell to another. They can transport proteins, lipids, RNA and other molecular information involved in cell communication.
A simple way to think about exosomes is as microscopic delivery packets. They do not become new tissue themselves. Instead, they carry messages that may influence how nearby or distant cells respond.
Exosomes are not stem cells or living cells. Researchers are studying their role in immune signaling, inflammation, tissue-repair communication and recovery.
Why Are Exosomes Getting Attention?
Exosomes are getting attention because they offer a cell-free way to study and potentially influence the signals cells use to communicate during injury, inflammation and tissue repair.
Unlike stem cell therapies, exosomes do not rely on living cells. Researchers are studying whether these molecular signals may help influence the surrounding tissue environment and support the body’s repair response.
Human research is expanding, but the science is still developing. At Karli Health, exosome therapy is evaluated as part of a broader regenerative medicine strategy rather than treated as a one-size-fits-all solution.
Where Do Exosomes Come From?
Exosomes are acellular extracellular vesicles naturally released by cells. They can come from a patient’s own blood, where platelets and other cells release extracellular vesicles, or from donor sources, including birthing tissues.
In the laboratory, the source cells or material are processed and, depending on the source, may be cultured to release extracellular vesicles. The vesicles are then collected, purified and concentrated for use.
These concentrated vesicles carry proteins, lipids, RNA and other molecular signals involved in cell-to-cell communication.
How Is Exosome Therapy Different From PRP and Stem Cell Therapy?
Exosome therapy delivers concentrated extracellular vesicles, the cell-released signaling particles described above, without administering living cells.
PRP uses a patient’s own blood to concentrate platelets and other important blood components, including leukocytes, growth factors and proteins.
Stem cell therapy uses living cells that are processed and administered as part of treatment.
The key difference is what is actually being delivered: concentrated signaling vesicles with exosome therapy, concentrated platelets and other blood components with PRP, or living cells with stem cell therapy.
What Is Exosome Therapy Used For?
Exosome therapy is being studied across several areas of regenerative medicine, including orthopedic injuries, joint and soft-tissue concerns, recovery, skin quality and hair restoration.
At Karli Health, patients commonly ask about exosome therapy for concerns such as:
Whether exosome therapy is appropriate depends on the condition being evaluated, prior treatments, imaging or diagnostic findings, medical history and physician assessment.
Explore Areas of Care
How Does Karli Health Approach Exosome Therapy?
At Karli Health, exosome therapy is evaluated as part of a broader physician-led regenerative medicine strategy, not as a one-size-fits-all treatment. The diagnosis, medical history, prior treatments, imaging or laboratory findings, goals and available regenerative options all help determine whether exosomes make sense for a particular patient.
When exosome therapy is used, the product source, stated dose, route of administration and treatment protocol are reviewed and documented. Patient-reported outcomes are then tracked through the Greyledge Data Cloud so response can be evaluated over time.
The Karli Standard remains the same: measure, treat, track, refine. For exosome therapy, that means knowing what product is being used, verifying the dose and documentation, matching the treatment to the patient and clinical goal, and tracking what happens next.
How Does Karli Health Evaluate Exosome Safety, Sourcing and Quality?
Exosome products can differ in where they come from, how they are processed and purified, how concentrated they are, and how the final product is characterized. Those differences matter because a product labeled “exosomes” does not automatically tell you exactly what is in the vial.
At Karli Health, available product documentation is reviewed before treatment, including the source, processing information, stated concentration or dose, testing and handling records. The goal is to know what product is being used, where it came from, and what documentation supports it.
Regulatory status, available evidence, potential risks and alternatives are discussed as part of the physician-led informed-consent process.
What Does Research Say About Exosome Therapy?
Research on exosome and extracellular vesicle therapies is growing, but the strength of the evidence varies depending on the condition or indication being studied, the source of the vesicles, how the product is processed and characterized, the dose and the route of administration.
So, does exosome therapy work? The most accurate answer is: it depends on what is being treated and what product and protocol are being studied. Some indications have progressed further into human clinical research than others.
One area receiving considerable attention is regenerative aesthetics, where human studies have reported improvements in wrinkles, skin texture, elasticity, pigmentation and hair-growth measures.
Orthopedic applications are also being studied, particularly knee osteoarthritis, with early human studies evaluating pain and function.
Researchers are also studying exosomes for neurological applications because extracellular vesicles can cross or interact with the blood-brain barrier, making them especially interesting for central nervous system research.
At Karli Health, published research is considered alongside the specific diagnosis, product source, dose, route of administration, safety and individual patient response. That’s why we are also tracking exosome treatments through the Greyledge Data Cloud.
Frequently Asked Questions
Candidacy depends on your diagnosis, medical history, prior treatments, imaging or laboratory findings, and what your goals are. Exosome therapy may be considered alone or alongside another regenerative treatment when appropriate.
Yes. We believe exosome therapy can be used safely in appropriately selected patients, and published human data to date has generally shown a favorable safety profile, with low rates of serious adverse events reported in studies. Because products and protocols vary, Karli Health reviews product documentation, source, dose and patient-specific risks before treatment.
Pricing depends on the treatment goal, dose and route of administration.
- Regenerative aesthetics: approximately $2,000–$4,000
- Orthopedic applications: approximately $5,000–$7,000, depending on whether treatment involves an injection, IV administration or both
- Wellness: exosome therapy may be incorporated into a Longevity Medicine package when appropriate
Ask your physician which approach fits your goals.
Yes. Depending on the condition and treatment goal, exosomes may be used alone or alongside PRP or another regenerative approach when medically appropriate.
Related regenerative therapies
PRP Therapy
Platelet-rich plasma prepared from your own blood, measured and dosed in our on-site lab.
Open PRP TherapyBone Marrow Concentrate — BMC
Your own bone marrow cells, concentrated and characterized before treatment.
Open Bone Marrow ConcentrateUmbilical Cord Cell Therapy
Ethically sourced donor cells used under Florida law, with full sourcing and screening standards.
Open Umbilical Cord Cell TherapyLOOK. FEEL. PERFORM GREAT.
Considering Exosome Therapy in Miami?
Exosome therapy is one of several regenerative options available at Karli Health. The right approach depends on your diagnosis, your goals, prior treatments and what makes sense for you medically.
David Karli, MD, MBA and the Karli Health team can help determine whether exosome therapy, PRP, cell therapy or another regenerative approach may be appropriate.
Medically reviewed by David Karli, MD, MBA · Harvard-trained physician, researcher and published author
Last reviewed: September 30, 2026